Skip to Content
Merck
  • Epigenetic upregulation of large-conductance Ca2+-activated K+ channel expression in uterine vascular adaptation to pregnancy.

Epigenetic upregulation of large-conductance Ca2+-activated K+ channel expression in uterine vascular adaptation to pregnancy.

Hypertension (Dallas, Tex. : 1979) (2014-06-11)
Man Chen, Chiranjib Dasgupta, Fuxia Xiong, Lubo Zhang
ABSTRACT

Our previous study demonstrated that pregnancy increased large-conductance Ca(2+)-activated potassium channel Ī²1 subunit (BKĪ²1) expression and large-conductance Ca(2+)-activated potassium channel activity in uterine arteries, which were abrogated by chronic hypoxia. The present study tested the hypothesis that promoter methylation/demethylation is a key mechanism in epigenetic reprogramming of BKĪ²1 expression patterns in uterine arteries. Ovine BKĪ²1 promoter of 2315 bp spanning from -2211 to +104 of the transcription start site was cloned, and an Sp1-380 binding site that contains CpG dinucleotide in its core binding sequences was identified. Site-directed deletion of the Sp1 site significantly decreased the BKĪ²1 promoter activity. Estrogen receptor-Ī± bound to the Sp1 site through tethering to Sp1 and upregulated the expression of BKĪ²1. The Sp1 binding site at BKĪ²1 promoter was highly methylated in uterine arteries of nonpregnant sheep, and methylation inhibited transcription factor binding and BKĪ²1 promoter activity. Pregnancy caused a significant decrease in CpG methylation at the Sp1 binding site and increased Sp1 binding to the BKĪ²1 promoter and BKĪ²1 mRNA abundance. Chronic hypoxia during gestation abrogated this pregnancy-induced demethylation and upregulation of BKĪ²1 expression. The results provide evidence of a novel mechanism of promoter demethylation in pregnancy-induced reprogramming of large-conductance Ca(2+)-activated potassium channel expression and function in uterine arteries and suggest new insights of epigenetic mechanisms linking gestational hypoxia to aberrant uteroplacental circulation and increased risk of preeclampsia.

MATERIALS
Product Number
Brand
Product Description

Supelco
Progesterone, VETRANALĀ®, analytical standard
Sigma-Aldrich
Progesterone, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
Progesterone, ≥99%
Sigma-Aldrich
Progesterone, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Progesterone, meets USP testing specifications
Supelco
Progesterone, Pharmaceutical Secondary Standard; Certified Reference Material
Progesterone for peak identification, European Pharmacopoeia (EP) Reference Standard
Progesterone for system suitability, European Pharmacopoeia (EP) Reference Standard
Progesterone, European Pharmacopoeia (EP) Reference Standard
USP
Progesterone, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
NuCLEARā„¢ Extraction Kit, For mammalian tissue or cultured cells
Roche
X-tremeGENEā„¢ HP DNA Transfection Reagent, High-performance polymer reagent for transfecting many cell lines